Drug
Apokyn
Apokyn: highest development phase Post-Market, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| APOKYN NCT01770145 | Post-Market | Parkinson's Disease |
Latest
No recent events.
Follow Apokyn on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.